A randomized, double‐blind, placebo‐controlled, multicenter, pilot study of the safety and feasibility of catheter‐based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease

Shmuel Fuchs, Nabil Dib, Barry M. Cohen, Petros Okubagzi, Edward B. Diethrich, Ann Campbell, Jennifer Macko, Paul Kessler, Henrik Rasmussen, Stephen E. Epstein,

Catheterization and Cardiovascular Interventions · 2006 · 60 citations · 21 references

Abstract

Percutaneous, catheter-based AdVEGF121 intramyocardial injection is a practical, feasible, and potentially safe approach for intramyocardial gene transfer. A larger randomized, phase II efficacy study is warranted.

References

21